Pinsent Masons advises Numis on £75 million Cambridge Innovation Capital fundraising

22 Aug 2016 | 03:21 pm |

International law firm Pinsent Masons has advised Numis on a £75 million fundraising for University of Cambridge investor, Cambridge Innovation Capital (CIC).

The funds will be used to provide investment to CIC's portfolio of technology businesses developed by the University of Cambridge and the wider Cambridge cluster, Europe's largest technology hub.

CIC launched in 2013 to provide growth capital to local tech businesses providing long term capital to support the sustained growth of investee companies.

A team at Pinsent Masons was led by corporate partner Russell Booker, assisted by corporate associate James Kaye.

Commenting on the deal Booker said: "This fundraising will be transformational for CIC and for the businesses it invests in. There has been a significant increase of new tech-based investment opportunities signalling a healthy pipeline of opportunities for CIC. We are delighted to have played a significant role in ensuring this valuable work continues."

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons announces launch of Netherlands presence

Multinational law firm Pinsent Masons has announced plans to launch a presence in Amsterdam, its first office in the Netherlands.

Pinsent Masons advises on 5G Create - the £28m government funded 5G test projects

Multinational law firm Pinsent Masons has advised the Department for Digital, Culture, Media and Sport (DCMS) on its innovative joint £28m investment in 5G test projects to showcase the capability of 5G technology across a range of industries and identify commercially sustainable long-term use cases.

Pinsent Masons advises GNA Biosolutions GmbH on Covid-19 rapid PCR test

Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts